Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective

Current Medical Research and Opinion

Volumn 25, Issue 6, 2009, Pages 1421-1431

  Hay, Joel W ^a   Kaliner, Michael A ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Allergy; Antihistamine; Healthcare costs; Histamine H1 antagonists; Perennial allergic rhinitis; Seasonal allergic rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; FIRST GENERATION ANTIHISTAMINIC AGENT; LEVOCETIRIZINE; LORATADINE; NON PRESCRIPTION DRUG; SECOND GENERATION ANTIHISTAMINIC AGENT; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANTICHOLINERGIC EFFECT; COMORBIDITY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG USE; HAY FEVER; HEALTH CARE COST; HUMAN; PRESCRIPTION; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; QUALITY OF LIFE; REVIEW; SEDATION; SENSITIVITY ANALYSIS; SIDE EFFECT; SINUSITIS; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ASTHMA; HEALTH CARE COSTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; OVERDOSE; RHINITIS, ALLERGIC, SEASONAL; UNITED STATES; WITHHOLDING TREATMENT;

EID: 67649429418     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902875992     Document Type: Review

References (32)

1. McCrory DC, Williams JW, Dolor RJ, et al. Management of allergic rhinitis in the working-age population. Agency for Healthcare Research and Quality. Available at: http://www.ahrq.gov/clinic/tp/rhinworktp.htm. Accessed: May 15, 2008
2. Seth D, Secord E, Kamat D. Allergic rhinitis. Clin Pediatr (Phila) 2007;46:401-407 (Pubitemid 47164888)
3. Diette GB, Markson L, Skinner EA, et al. Nocturnal asthma in children affects school attendance, school performance, and parents' work attendance. Arch Pediatr Adolesc Med 2000;154:923-928 (Pubitemid 30692277)
4. Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000;162(4 Pt 1):1391-1396 (Pubitemid 30826160)
5. Majani G, Baiardini I, Giardini A, et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001;56:313-317 (Pubitemid 32222611)
6. Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209-213
7. Hemp P. Presenteeism: at work - but out of it. Harv Bus Rev 2004;82:49-58 (Pubitemid 39383391)
8. Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006;22:1203-1210 (Pubitemid 44000740)
9. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 Summary. Advance Data from Vital and Health Statistics: No.387. National Center for Health Statistics, US Dept of Health and Human Services. Available at: http://www.cdc.gov/nchs/data/ad/ad387.pdf. Accessed: May 12, 2008
10. Soni A. Allergic rhinitis: trends in use and expenditures, 2000 and 2005. Statistical Brief #204. Agency for Healthcare Research and Quality. Available at: http://www.meps.ahcpr.gov/mepsweb//data-files/publications/st204/stat204. pdf. Accessed: June 18, 2008
11. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
12. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. 1998;81(5 Pt 2):478-518 (Pubitemid 28553778)
13. Dalal AA, Stanford R, Henry H, et al. Economic burden of rhinitis in managed care: a retrospective claims data analysis. Ann Allergy Asthma Immunol 2008;101:23-29 (Pubitemid 352000740)
14. Crystal-Peters J, Crown WH, Goetzel RZ, et al. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000;6:373-378 (Pubitemid 30171343)
15. Hayden ML, Womack CR. Caring for patients with allergic rhinitis. J Am Acad Nurse Pract 2007;19:290-298
16. Lanier B. Allergic rhinitis: selective comparisons of the pharmaceutical options for management. Allergy Asthma Proc 2007;28:16-19
17. Juniper EF. Quality of life in adults and children with asthma and rhinitis. Allergy 1997;52:971-977 (Pubitemid 27455908)
18. Simons FE. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996;17:185-189 (Pubitemid 26275396)
19. Sullivan PW, Follin SL, Nichol MB. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis. Pharmacoeconomics 2004;22:929-942 (Pubitemid 39382186)
20. Bachert C, Van CP. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review. Clin Ther 2007;29:1795-1802
21. Verster JC, Volkerts ER, van Oosterwijck AW, et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 2003;111:623-627 (Pubitemid 36337888)
22. Passalacqua G, Canonica GW. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther 2005;27:979-992 (Pubitemid 41262456)
23. Gillard M, Christophe B, Wels B, et al. H1 antagonists: receptor affinity versus selectivity. Inflamm Res 2003;52(Suppl 1):S49-50 (Pubitemid 36470055)
24. Lee J, Cummins G, Okamoto L. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis. Am J Manag Care 2001;7(4 Suppl):S103-12 (Pubitemid 32433037)
25. Liao E, Leahy M, Cummins G. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis. Am J Manag Care 2001;7(15 Suppl):S459-68 (Pubitemid 33039735)
26. Dehejia RH, Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev Economics Stat 2002;84:151-161
27. Hay JW. Appropriate econometric methods for pharmacoeconometric studies of retrospective claims data: an introductory guide. J Manag Care Pharm 2005;11:344-348
28. Hay JW, Leahy M. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program. Value Health 2005;8:506-516 (Pubitemid 41726104)
29. Sullivan PW, Follin SL, Nichol MB. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Med Care 2003;41:1382-1395
30. Sullivan PW, Nair KV, Patel BV. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Am J Manag Care 2005;11:374-382 (Pubitemid 40875306)
31. Gelfand EW. Pediatric allergic rhinitis: factors affecting treatment choice. Ear Nose Throat J 2005;84:163-168 (Pubitemid 43093477)
32. Hansen J, Klimek L, Hormann K. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging 2005;22:289-296 (Pubitemid 40656018)